HUMIRA is a whole different way to treat HS.
While many medicines have played a role in treatment, there have been no FDA-approved treatments for moderate to severe hidradenitis suppurativa (HS). HUMIRA is the first and only FDA-approved hidradenitis suppurativa treatment.
HUMIRA targets a source of HS inflammation.
While the exact cause is unknown, medical science has shown that HS is an immune disease. With HS, your body produces too much of a protein called TNF-alpha. This, along with other proteins, leads to increased inflammation. Which in turn leads to abscesses that may appear underneath or on the surface of your skin. So it’s active inside your body, but visible on the outside. HS is a chronic disease, which means it’s a disease that lasts a long time.
HUMIRA targets and blocks TNF-alpha, a specific source of inflammation that is thought to contribute to HS symptoms. Many HS patients who used HUMIRA in clinical trials experienced significant relief.
In just 3 months, HUMIRA was proven in many patients to reduce inflammatory nodules and abscesses by at least half without developing any new draining wounds and abscesses. Your results may vary.
A dermatologist specializes in treating skin diseases like HS.
A dermatologist, a doctor who treats skin diseases, knows the underlying cause of HS and the latest ways to treat it, including HUMIRA.
A little preparation can help you have a better conversation with your dermatologist.
Watch how HUMIRA helped change the HS stories of these moderate to severe HS patients.
Go to HS YearbookUS-HUM-181266
